Ischemia--reperfusion (I/R) injuries are recognized as one of the key factors in the exacerbation of cardiovascular diseases.^[@bib1]^ Ischemic preconditioning (IPC), using a few cycles of short ischemic period, is shown to protect against I/R damage in cardiac muscles.^[@bib2]^ It has been speculated that IPC could correlate to signaling cascades initiated by reactive oxygen species (ROS),^[@bib2]^ yet, the exact redox mechanisms of IPC has not been thoroughly elucidated. For example, there is a lack of direct evidence for ROS formation measured at the onset of ischemia in an intact heart. The source of ROS formation has not been determined during early ischemia, which correlates to the timeframe of IPC.

Oxymyoglobin (Mb) has been shown to have a role in alleviating I/R injuries.^[@bib3],\ [@bib4]^ However, the complete mechanism of its protective action is still unclear. Mb has one O~2~ binding site consisting of heme, which is a prosthetic group containing an iron (Fe) ion. Mb functions as both an O~2~ storage site under normal conditions and an O~2~ supply during temporary deficits.^[@bib5]^ The oxygen binding properties of Mb are contingent upon the oxidation state of Fe within the heme group. Ferrous heme (Fe^2+^) is found in the reduced form of Mb and can function as an O~2~ binding site. In contrast, when ferric heme (Fe^3+^) is present in the Mb complex, O~2~ binding cannot occur. One key physiological result of Fe^2+^ oxidation is the generation of superoxide (O~2~^•--^) through the following reaction:^[@bib6]^

Fe^2+^+O~2~ → Fe^3+^+O~2~^•--^

O~2~^•--^, a type of ROS, is a biologically important signaling molecule involved in many physiological and pathological processes, including hypoxia, heat stress, septic shock, and muscle dysfunction.^[@bib7]^ Increased O~2~^•--^ formation following ischemia is associated with the pathogenesis of I/R injury.^[@bib8]^ Oxidative damage during I/R is commonly linked to the formation of O~2~^•--^ and generally attributed to reperfusion, a process in which restored flux of O~2~ encounters a highly reduced environment of ischemic tissue, leading to tissue damage.^[@bib9],\ [@bib10]^ As the correlation between O~2~^•--^ formation and reperfusion injury has been well studied in the past decade,^[@bib11],\ [@bib12],\ [@bib13]^ we are primarily focused on O~2~^•--^ formation at the early phase of ischemia, which is understudied.

O~2~^•--^ and O~2~^•--^-derived oxidants can be formed during the early period of reperfusion.^[@bib1]^ Some research showed that this oxidative burst is attributed to the accumulation of xanthine during ischemia and the activation of xanthine oxidase (XO) enzyme at reperfusion.^[@bib9]^ Other researchers suggested that the mitochondrion is a primary source.^[@bib14]^ However, O~2~^•--^ formation has not been reported during the onset of myocardial ischemia in a Langendorff heart model.^[@bib15]^ Furthermore, the mechanism of O~2~^•--^ production during early ischemic period has been largely overlooked. It is likely that this may be correlated to IPC, which employs brief cycles of ischemia and has been shown to have a critical role in cardiac therapeutics.^[@bib2]^ The production of O~2~^•--^ at the early ischemia may possibly protect an ischemic heart from further damage during reperfusion via IPC signaling cascades.^[@bib2]^

We have previously identified a large burst of O~2~^•--^ formation during reperfusion in both *in vivo* and *in vitro* heart models.^[@bib1],\ [@bib16]^ Thus, the current research is primarily focused on the O~2~^•--^ formation at early ischemia. We have designed an innovative study which demonstrates that O~2~^•--^ formation occurs during the onset of ischemia (within the first min). Using an isolated perfused rat heart model, the intracellular O~2~^•--^ formation is detected by a fluorescent O~2~^•--^ probe. We hypothesize that Mb oxidation (Fe^2+^→Fe^3+^) coupled with the production of O~2~^•--^ may occur during early ischemia. The current study may help to develop new therapeutic preconditioning methods for I/R injuries, which is consistent with previous research showing that Mb is a potentially protective element during I/R through redox pathways.^[@bib3]^

Results
=======

Previous studies have chemically demonstrated that the autoxidation reaction of Mb (Fe^2+^) to MetMb (Fe^3+^) results in the accompanied formation of O~2~^•--^.^[@bib17],\ [@bib18]^ In order to determine whether O~2~^•--^ production in real time occurs within the ischemic cardiac tissue, ethidium (ET) fluorescence was monitored in an isolated rat heart with or without ischemia treatment, and recorded in a relative unit using the surface fluorometric method described above. As shown in [Figure 1](#fig1){ref-type="fig"}, a rapid increase in ET fluorescence (∼18% of baseline from autofluorescence) was detected within 3 min after the onset of ischemia and reached ∼24% of baseline at 9 min of the ischemic period, as compared with all other treatments (*n*=5; *P*\<0.05). Meanwhile, autofluorescence decreased in non-loaded ischemic hearts (∼10% at 20 s from the start of ischemia; *n*=3). This change in the basal fluorescence was likely due to the autofluorescence of intracellular flavine adenine dinucleotide (FAD), which decreased during the course of ischemia or hypoxia in striated muscles.^[@bib19]^ To confirm that the elevated ET fluorescence was due to O~2~^•--^ production in the ischemic heart, superoxide dismutase (SOD) mimetic was used, and it turned out that the increase of ET fluorescence in the ischemia heart was subsequently abolished (*n*=8). To further analyze the involvement of Mb in O~2~^•--^ production, we treated the hearts with a CO solution (10%) that potentially blocks ferro-metallo proteins such as Mb from binding to oxygen, which chemically eliminates the formation of O~2~^•--^.^[@bib6]^ CO treatment reduced ET fluorescence in the ischemic heart compared with the pure ischemia group (*n*=4). These results strongly indicate that Mb is involved in O~2~^•--^ formation in the heart at the early onset of ischemia.

As we observed significant O~2~^•--^ generation within 3 min of ischemia ([Figure 1](#fig1){ref-type="fig"}), it is critical to explore this phenomenon in a micro time course during a 1-min period, as illustrated in [Figure 2](#fig2){ref-type="fig"}. During the first 12 s of ischemia, there was no obvious change of ET fluorescence. However, at 16 s, the fluorescence started to increase to ∼12% of baseline compared with autofluorescence and reached a peak of ∼18% at 20 s after ischemia. These increases were significant compared with all other groups (*n*=3; *P*\<0.05), which suggest that O~2~^•--^ generation in the heart is an immediate response to ischemia.

Mean fluorescence rate (averaged by three rat hearts) was calculated over a micro time course of 60 s immediately following the ischemia period, and was displayed in a relative unit per second. In the ischemia-only group, there are two large spikes (representing rapid increases) and one small spike (for slow increases) on the ET signal rate. Among these three spikes, the first one appears as early as 8 s, the middle one shows at 24 s, and the last one (the smallest) occurs at ∼44 s. This clearly demonstrated that two large O~2~^•--^ bursts occurred within 24 s from the start of ischemia ([Figure 3a](#fig3){ref-type="fig"}). We also noticed that the second peak was∼25% greater than the first one. These spikes were suppressed in both SOD mimic ([Figure 3b](#fig3){ref-type="fig"}) and CO groups ([Figure 3c](#fig3){ref-type="fig"}), which indicated a possible involvement of Mb in determination of O~2~^•--^ generation rate. There were no positive spikes in baseline autofluorescence, but a large negative spike was observed, showing that O~2~^•--^ signal should overcome the autofluorescence decline first before it rises up (as shown in the ischemia group). Thus, we underestimated the increased O~2~^•--^ signal, which would otherwise have been more significant ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}).

In order to further confirm the role of Mb in O~2~^•--^ generation in other rodent models, Myo−/− mice and wild-type mice were used following a similar protocol in the rat experiments. As early as 20 s from the start of ischemia, fluorescence was enhanced (∼4% greater than baseline autofluorescence) and maintained throughout the ischemic period in wild-type mice compared with Myo−/− mice (*n*=4; *P*\<0.05; [Figure 4](#fig4){ref-type="fig"}). Interestingly, fluorescence from Myo−/− mice decreased in a manner similar to autofluorescence as shown in [Figure 4](#fig4){ref-type="fig"}, suggesting that Mb have an important role in O~2~^•--^ generation in early ischemia.

Similar to the rat study, the mean rate of increase of ROS fluorescence during the first 60 s of ischemia was calculated in the transgenic mouse model. In the wild-type mice group, a spike in the mean rate of ET signal was observed as early as 16 s ([Figure 5a](#fig5){ref-type="fig"}). However in Myo−/− group, this spike disappeared, but a negative spike occurred at 4 s ([Figure 5b](#fig5){ref-type="fig"}), which is similar to the response curve from the autofluorescence in rat ([Figure 3d](#fig3){ref-type="fig"}).

To determine the cellular location and the source of O~2~^•--^ production, we analyzed ET fluorescence in an ischemic heart using confocal microscopy via dual-labeling of the myocytes and endothelial cells. [Figure 6a](#fig6){ref-type="fig"} showed that the baseline fluorescence before ischemia treatment is kept at a minimal level. [Figures 6b and c](#fig6){ref-type="fig"} represent the fluorescent images at 3 min of ischemia, which are brighter in red compared with [Figure 6a](#fig6){ref-type="fig"}. This suggests that the early generation of O~2~^•--^ in response to ischemia. As shown in [Figure 6c](#fig6){ref-type="fig"}, the increase of ischemia-induced fluorescence originated from cardiomyocytes ([Figures 6b and c](#fig6){ref-type="fig"}; the red represents ROS formation and the green represents endothelium), but not endothelial cells (shown in green in [Figure 6c](#fig6){ref-type="fig"}) because there was clearly no overlap between the two dyed areas. These results confirmed that O~2~^•--^ formation occurred in the Mb-rich cardiac muscle tissue but not in the endothelial tissue.

Discussion
==========

This is the first study demonstrating that Mb is a major source of O~2~^•--^ formation at the onset of ischemia in a Langendorff heart model. Our data provide an insight into the molecular mechanism of IPC which utilizes ROS generated during early ischemia to protect the cardiomyocytes via redox signaling cascades.^[@bib2]^

The generation of reactive, partially reduced oxygen species has been well established as a causative factor for tissue damage that occurs during reperfusion of a previously ischemic tissue.^[@bib20]^ Protection against oxidant injury is particularly meaningful during the early reperfusion period after an ischemic insult, which is characterized by the sudden formation of large amounts of O~2~^•--^.

Former research assumed that sources such as XO, NADPH oxidase, and the mitochondrial electron transport chain are the primary sources of ROS development during ischemia.^[@bib15],\ [@bib21],\ [@bib22]^ Other research has shown that ROS formation occurs during extended simulated ischemia (1 h) using cell culture system.^[@bib15]^ However, there is no convincing evidence showing any ROS generation in the early stage of cardiac ischemia in a whole-heart model. Yet, the enzyme XO, which oxidizes purines such as hypoxanthine and xanthine to produce uric acid and O~2~^•--^, has received a great deal of experimental attention as a source of O~2~^•--^ during reperfusion,^[@bib23]^ but not at the onset of ischemia. Likewise, the mitochondrion is an additional possible source of ROS generation, but has not previously been reported its correlation to ROS formation during early ischemia.^[@bib24]^

As questions have remained regarding the production of ROS at the early onset of ischemia, our work has filled the gap of previous knowledge by investigating the potential role of Mb in the production of ROS during ischemia in a Langendorff model. Mb is a ubiquitous protein that is present in the cardiac muscle at relatively high concentrations, and has also been viewed to facilitate the diffusion of O~2~ in the cardiac muscle.^[@bib25]^ Even under normal conditions, Mb undergoes reactions that generate metMb (Fe^3+^) species and O~2~^•--^.^[@bib26]^ Yet, the function of Mb has not been previously identified as a potential factor in ROS formation during ischemia. Therefore, the demonstration of O~2~^•--^ production by Mb gives a new perspective on the mechanism of O~2~^•--^ formation at the onset of ischemia.

From our previous research^[@bib16]^ and current data, this amount of O~2~^•--^ is small compared with reperfusion-induced ROS, which is ideal for preconditioning signal.^[@bib2]^ In addition, our protocol used CO treatment coupled with ischemia to verify that MbO~2~ autoxidation is a primary source of O~2~^•--^ generation. As shown in [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, the fluorescence levels were significantly lower in the ischemia with CO model compared with ischemia alone. As there is no hemoglobin in our Langendorff perfusion apparatus, the binding of CO to the cardiac Mb in our set up effectively prevents O~2~^•--^ formation. [Figure 6](#fig6){ref-type="fig"} confirmed that O~2~^•--^ does not originate from Mb-deficient vasculatures but rather from the myocytes, whereby the amount of Mb is abundant.

At ∼20 s from the start of ischemia, the increase of O~2~^•--^ signal in rat models (∼18%\>baseline autofluorescence, [Figure 2](#fig2){ref-type="fig"}) was larger than the mouse model (∼4%\>baseline autofluorescence, [Figure 4](#fig4){ref-type="fig"}). Similarly, in the curves from the mean rate of ROS fluorescence, the rat model had two large O~2~^•--^ bursts ([Figure 3](#fig3){ref-type="fig"}), whereas the mouse model only had one, which is ∼60% smaller ([Figure 5](#fig5){ref-type="fig"}). This difference is possibly owing to the usage of different animal models (rat *versus* mouse). We also noticed that CO only blocked ∼70% of the ischemic signal, whereas almost 100% of the signal was inhibited by the SOD mimic within 20 s after the ischemia started in the rat model ([Figure 2](#fig2){ref-type="fig"}). We initially speculated that mitochondria or other ROS generators accounted for this ∼30% difference in the blockage of O~2~^•--^ signals. However, this is unlikely because the ROS signal was completely abolished in the transgenic Myo−/− mouse model ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}), suggesting the key role of Mb in O~2~^•--^ formation. Thus, it is probably due to the partial blockage of Mb by CO as a relatively low dosage of CO as well as a short incubation period was used. Yet, it is difficult to increase this dosage to a greater level as higher levels of CO could directly cause irreversible cardiac failure.

There are other limitations associated with CO blockage. As the Ki of CO for cytochrome oxidase is of the same order as the Km for oxygen,^[@bib27]^ the 10% proportion of CO in the gas phase would result in about 10% inhibition of cytochrome oxidase under aerobic conditions. However, when oxygen is depleted upon ischemia, the addition of CO not only blocks Mb function but also inhibits mitochondrial cytochrome oxidase during ischemia. Thus, it is critical to perform Myo−/− mice experiments to verify the role of Mb in our setup.

During the first 60 s from the start of ischemia, the O~2~^•--^ formation rate is not constant, that is, the generation of O~2~^•--^ was not continuous, including the first two larger ROS bursts at 8 s and 24 s respectively, followed by an extremely small burst (∼ one-third of the previous one) at 44 s ([Figure 3a](#fig3){ref-type="fig"}). This suggested a possible involvement of endogenous antioxidant enzymes such as SOD, catalase, and glutathione peroxidase during early ischemia, which gradually attenuated the O~2~^•--^ formation rate.^[@bib19]^

From a clinical perspective, an oxidative burst occurs in the myocardium during open heart surgery as a result of reperfusion injury following ischemia.^[@bib28]^ This oxidative stress overwhelms the antioxidant defense system and leads to DNA damage and protein degradation.^[@bib28]^ Hypoxic preconditioning (HPC) partially simulates early hypoxia or ischemia by using a few cycles of short hypoxia treatment to protect skeletal muscles from oxidative damage.^[@bib29]^ Our previous work further identified a plausible cellular signaling mechanism of HPC involves a phosphatidylinositol 3-kinase (PI3K), which also has a crucial role in cardiomyocyte protection from I/R injury.^[@bib29],\ [@bib30]^ Similar to HPC, IPC uses a few short cycles of ischemia, which significantly protects cardiac muscle from I/R injury through the opening of mitochondrial ATP potassium channels (K~ATP~ channel).^[@bib2]^ IPC or HPC can potentially initiate the PI3K signaling pathway to inhibit glycogen synthase kinase-3*β*, which has beneficial effects on cardiomyocytes,^[@bib31]^ as the activation of glycogen synthase kinase-3*β* leads to mitochondrial permeability transition pore opening, therefore disrupting ATP synthesis.^[@bib2]^

Interestingly, confocal data from previous HPC research illustrated that intramuscular ROS formation significantly decreases after HPC treatment,^[@bib29]^ and thus it is likely that PI3K activated by HPC can enhance antioxidant defenses in the cardiac muscle as it has done in the skeletal muscle. Furthermore, the activation of mitochondrial K~ATP~ channels has been shown in several studies to have a role in preconditioning;^[@bib32],\ [@bib33]^ however, it was recently suggested that the opening of mitochondrial K~ATP~ channels initiates the preconditioning by producing free radicals.^[@bib34]^ Antioxidants applied before IPC or HPC treatment significantly decrease the cardioprotection during I/R.^[@bib2]^ These studies strongly suggest that the generation of free radicals such as O~2~^•--^ during IPC is necessary to trigger an inherent protective mechanism of preconditioning. The oxygenation and deoxygenation of Mb and the resulting small formation of O~2~^•--^ identified in our current research likely occurs during IPC. Our identification of Mb as a novel O~2~^•--^ generator in cardiomyocyte ischemia gives it an anticipated role in cardioprotection for ischemic injuries.

Our result contradicts Schrader and group\'s^[@bib35]^ previous study, which showed that O~2~^•--^ production decreased to zero within seconds upon ischemia onset and stayed at such a level until reperfusion. Such a disparity may have been a result of the substantially different technology used in our study compared with that of the Schrader\' experiments. Unlike the experiments conducted by Schrader and group\'s^[@bib35]^, we utilized a fluorescent probe rather than a chemiluminescence probe lucigenin. Previous research has raised significant concerns on the effectiveness of lucigenin for the detection of O~2~^•--^. For instance, in various models, the fluorescent O~2~^•--^ probes appear to be sensitive in detecting residual O~2~^•--^ than chemiluminescent probes. Moreover, lucigenin-based measurements of O~2~^•--^ can cause artifacts in NADPH-rich tissues, such as cardiac or skeletal muscles.^[@bib36],\ [@bib37],\ [@bib38],\ [@bib39],\ [@bib40]^ The fluorescence probe, dihydroethidium (DHE), is highly sensitive and capable of detecting weak intramuscular O~2~^•--^ signals in both rodent muscle and myocyte models, whereas chemiluminescence is less adapted in detecting small O~2~^•--^ signals.^[@bib1],\ [@bib16],\ [@bib41],\ [@bib42],\ [@bib43],\ [@bib44],\ [@bib45]^ Thus, the fact that O~2~^•--^ production decreased to zero within seconds upon ischemia in Schrader\'s observation may be possibly due to the lack of sensitivity.

Budd *et al.*^[@bib46]^ showed that uncoupler-induced ET fluorescence increase is not due to an increase in O~2~^•--^ production but results from the collapse of the mitochondrial membrane potential, because oxidized DHE (2-hydroxyethidium and ET) behaves as a mitochondrial membrane potential probe. Thus, their research suggested that the loading concentration of DHE should be kept sufficiently low (i.e., 5 *μ*M) in cell culture or mitochondrial suspensions. This dosage is highly consistent with our former study which used the isolated cardiomyocytes.^[@bib41]^ However, Budd *et al.*^[@bib46]^ had a loading condition that was set for the cell culture system (i.e., 5 *μ*M for 10 min); in our study, we were using a rodent heart, which is comprised of hundreds of tissue layers that required high-loading concentrations compared with that of the cell culture. Although we used a range of 1--10 *μ*M of DHE to load the heart, we were unable to detect any signal from the heart during these preliminary tests. Following the previous effective loading protocols for the multilayer muscle tissue,^[@bib42]^ our current loading concentration is set higher (44 *μ*M) and the loading time is set much shorter (1.5 min) than those of the cells. This procedure is immediately followed by a 5 min washout, to remove excess dye, and a short ischemia protocol. It is worth noting that former research has also shown that it typically requires a longer time (i.e., 60 min or longer) for a fluorescent probe to successfully load into the mitochondria in cultured cardiomyocytes.^[@bib47]^ It is likely that the loading time for mitochondria in the whole heart (used in out experiments) may be even longer. Therefore, it is very unlikely that within such a short period (1.5 min in our assay) the DHE probe has sufficient time to reach the mitochondrial compartment to cause any artificial signals owing to the collapse of mitochondrial membrane potential.

Conclusion and significance
---------------------------

Through the use of SOD mimic, CO treatments, and Mb-knockout techniques, we have identified Mb as a novel O~2~^•--^ generator in the cardiac myocyte during the onset of ischemia. A small burst of O~2~^•--^ that was produced by Mb within 20 s of ischemia may be correlated with IPC preconditions, though this mechanism has not been thoroughly investigated. For future studies, other biological techniques such as electron paramagnetic resonance may be used to quantify O~2~^•--^ signals in this model, and explore a more specific role of Mb in cardiac protection, which facilitates the understanding of the molecular signaling pathways for IPC and O~2~^•--^ development during ischemia.

Materials and Methods
=====================

Rat Langendorff heart perfusion
-------------------------------

Male Sprague--Dawley rats weighing ∼350 g were anesthetized with pentobarbital (∼50 mg/kg intraperitoneal injection). After hemithoractomy, hearts were rapidly excised, and aorta were cannulated under retrograde coronary perfusion at 80 mm Hg with Krebs-Henseleit buffer (120.0 mM NaCl, 5.9 mM KCl, 2.5 mM CaCl~2~, 1.2 mM MgCl~2~, 16.7 mM glucose, 25.0 mM NaHCO~3~, 0.5 mM EDTA, bubbled with 95%/5% O~2~/CO~2~).^[@bib1]^ Hearts were mounted on a Langendorff perfusion apparatus. Each heart was perfused until the recovery of steady cardiac frequency at 37 °C for 15 min. Ischemia was induced by the stopping of the flow of perfusate.

Mb-knockout mice
----------------

Mb-knockout (Myo−/−) mice were generated by deletion of the essential genes of Mb in embryonic stem cells, as described previously.^[@bib48]^ Mice were genotyped when they were weaned. The experimentation was performed using male mice, and tail clips were kept to reconfirm the genotypes. Both Myo−/− and wild-type mice were heparinized (500 U/kg) and anesthetized via intraperitoneal injection with a combination of ketamine (70 mg/kg) and xylazine (10 mg/kg). After hemithoractomy, hearts were rapidly excised and mounted in a Langendorff perfusion apparatus following the similar protocol to the rat experiments.

Carbon monoxide perfusion
-------------------------

Carbon monoxide (CO) was used to block the O~2~ binding to Mb. In addition to the Langendorff heart protocol, CO was fully equilibrated with gas sampling tube for 20 min. At 37 °C, Krebs-Henseleit buffer flow rate was 16.2 ml/min and the adjacent tube of CO had a flow rate of 1.8 ml/min. Thus, the overall CO flow rate was set at 10% of the total flow rate, which was 18 ml/min (16.2+1.8=18) for 5 min.

Surface fluorometry
-------------------

We measured changes in radical formation in the early ischemia in an isolated rodent (rat/mouse) heart. A fiber optic probe was positioned facing the left ventricle in order to obtain an emission signal from the heart. The distance between the heart and cable surface was adjusted to minimize the motion artifact. DHE/ET fluorescence was used as a non-charged O~2~^•--^-sensitive probe. DHE (Molecular Probes/Life Technologies, Grand Island, NY, USA) stock was dissolved in *N,N*-dimethylacetamide (Acros Organics/Thermo Fisher Scientific, Waltham, MA, USA). In response to O~2~^•--^, DHE is dehydrogenated, resulting in the formation of 2-hydroxyethidium, which is relatively unstable and converts to a stabilized ET.^[@bib41],\ [@bib49]^ ET is positively charged and has better cellular retention and stability when compared with DHE.^[@bib42]^ Therefore, ET formation was chosen as a reliable indicator of O~2~^•--^ production.^[@bib43],\ [@bib44],\ [@bib46]^ The ET excitation filter was set at 515±20 nm, and the ET emission was set within a range of 590±25 nm. The emitted fluorescent signal was recorded every 4 s and then transmitted to a computer through an A/D board. A mean fluorescence rate was used to monitor the ET signal change per second at each specific time. A fresh DHE solution was made before dye injection into the heart. Thus, any oxidation of DHE in the solution that bubbled in 95% O~2~ was kept at a minimal.^[@bib50]^ Hearts were perfused with 44 *μ*M DHE for 1.5 min at a perfusion rate of 1 ml/min, followed by a short global ischemia. To confirm that fluorescence was in fact trigged by a burst of O~2~^•--^ production, a group of hearts were perfused with both the SOD mimic Mn(III)tetrakis(1-methyl-4-pyridyl) porphyrin (MnTMPyP, Enzo Life Sciences/Alexis Biochemicals, Farmingdale, NY, USA; 250 *μ*M) and DHE before ischemia as negative controls.

Confocal study
--------------

Langendorff rat hearts were first perfused with a solution of DHE (44 *μ*M) to detect O~2~^•--^ and fluorescein lectin I-isolectin B4 (FLI-IB4, 0.67 *μ*g/ml, Vector Labs, Burlingame, CA, USA) as a marker for intracellular endothelium for 1.5 min at 1 ml/min. The excess dye was washed out for 5 min with buffer. Hearts were immobilized by an actin--myosin complex blocker 2,3-butanedione monoxime (4 mM; Acros Organics),^[@bib42]^ transferred to the confocal microscope stage, and perfused with 37 °C buffer for ∼5 min immediately followed by an ischemic period. The confocal images were recorded when the heart was in an ischemia condition.

The set up for laser scan confocal imaging of O~2~^•--^ was the following: Laser: argon; objective, × 40 with 1.5-mm working distance; ET excitation, 568 nm; ET emission, long pass (LP, 590 nm). The autofluorescence background was kept minimal in the current settings. Images of the emitted fluorescence signals were captured by a photomultiplier tube and transferred to a computer monitor that displayed them at 512 × 512 pixels for analysis.^[@bib1],\ [@bib42]^

Statistical analysis
--------------------

Data are expressed as mean±S.E., unless noted otherwise. The statistical significance of differences between groups was calculated using two-way analysis of variance. The *P*-values of\<0.05 were considered significant.
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![Fluorescence levels over the time course of 9 min in ischemia, ischemia with CO treatment, ischemia with SOD mimic treatment, and autofluorescence. \**P*\<0.05, ischemia *versus* all other groups](cddis2013313f1){#fig1}

![Zoomed fluorescence levels over the micro time course of 60 s in ischemia, ischemia with CO treatment, ischemia with SOD mimic treatment, and autofluorescence. \**P*\<0.05, ischemia *versus* all other groups](cddis2013313f2){#fig2}

![Mean fluorescence rate (fluorescence change per second; relative unit per second, RU/s) over the time course of 60 s from the start of ischemia in rat heart. (**a**) mean fluorescence rate in the ischemia-only group. (**b**) mean fluorescence rate in SOD mimic treatment group. (**c**) mean fluorescence rate in CO treatment group. (**d**) mean fluorescence rate in autofluorescence group (*n*=3)](cddis2013313f3){#fig3}

![Fluorescence levels over the time course of 60 s from the start of ischemia. \**P*\<0.05, *n*=4; Mb-knockout (Myo−/−) mice *versus* wild-type (WT) mice](cddis2013313f4){#fig4}

![Mean fluorescence rate (fluorescence change per second; RU/s) over the time course of 60 s from the start of ischemia in a mouse heart. (**a**) mean fluorescence rate in WT mice. (**b**) mean fluorescence rate in Myo−/− mice (*n*=4)](cddis2013313f5){#fig5}

![Localization of O~2~^•--^ formation during the onset of ischemia on the heart surface using confocal microscopy. (**a**) heart baseline fluorescence before ischemia. (**b**) O~2~^•--^ generation in the HE-loaded heart within 3 min during ischemia. (**c**) O~2~^•--^ generation in hearts treated with dual-fluorescence probes (HE and fluorescein lectin I-isolectin B4 (FLI-IB4)), showing that O~2~^•--^ production is within the cardiomyocytes, not in the endothelial vessels](cddis2013313f6){#fig6}
